| Mifeprex (mifepristone) / Danco Laboratories |
ChiCTR-TRC-11001438: Combination of mifepristone and misoprostol for termination of 8-16 weeks' pregancy: a multicenter, randomized controlled study |
|
|
| Completed | 4 | 1200 | | Day 1: mifepristone 200mg; Day 2: misoprostol vaginally 600mcg, q3h, up to 4 times ;Day 1: mifeprisone 200mg; Day 2: misoprostol vaginal 600mcg, then misoprostol orally after 3 h , up to 4 times ;Day 1: mifepristone 200mg; Day 2: misoprostol orally 600mcg, q3h, up to 4 times ;Day 1: mifepristone 100mg; Day 2: mifepristone 100mg; Day3: misoprostol 600mcg vaginal, q12h, up tp 3 times | Shanghai Institute of Planned Parenthood Research; Hualian Pharmaceutical Co., LTD, Shanghai Science and Technology Committee | medical abortion for 8-16 weeks' pregnancy | | | | |
2014-002974-35: Is home abortion mora acceptable for teenagers than abortion at the clinic? A randomized trial. |
|
|
| Ongoing | 4 | 160 | Europe | Tablet, Mifegyne, Cytotec, Naproxen, Alvedon | Umeå University, Umeå University | Young women with unwanted pregnancies seeking abortion care, Young women with unwanted pregnancies seeking abortion care, Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
NCT01799928: Cervical Ripening Before Dilation and Evacuation |
|
|
| Recruiting | 4 | 50 | US | Placebo-Vitamin C pill, Osmotic Dilator, 400 mcg buccal misoprostol, 200 mg mifepristone | Oregon Health and Science University, Planned Parenthood Federation of America | Cervical Preparation Preoperatively to Dilation and Evacuation | 03/15 | | | |
2010-023849-30: The effects of MR and GR blockade on the reconsolidation and extinction of fear memories |
|
|
| Ongoing | 4 | 120 | Europe | Spironolactone, Mifepristone, RVG 18639, RVG 24206, Spironolactone, Mifepristone, Spironolactone, Mifepristone | University of Amsterdam | Fear conditioning acquisition, reconsolidation and extinction in healthy male subjects. | | | | |
2009-010277-21: A Randomised Controlled Trial on Efficacy of mifepristone followed by 6-8 hours versus 24 hours vaginal misoprostol in Early Pregnancy Abortions (< 63 days gestations) |
|
|
| Ongoing | 4 | 1200 | Europe | Mifepristone, Misoprostol, Mifegyne, Cytotec, Mifegyne, Cytotec | Calthorpe Clinic | Medical termination of pregnancies before nine weeks of pregnancy | | | | |
| Ongoing | 4 | 52 | Europe | Mifepristone, Mifegyne, Mifegyne | Kings College London, South London and Maudsley NHS Foundation Trust, Medical Research Council | Alcoholism | | | | |
2004-002920-17: A randomised preference trial of medical versus surgical termination of pregnancy less that 14 weeks\' gestation |
|
|
| Ongoing | 4 | 2232 | Europe | misoprostol, mifepristone, Cytotec, Mifegyne, Cytotec, Mifegyne | Department of Health | termination of pregnancy | | | | |
2013-001554-10: The comparison of two drug treatments for miscarriage Het vergelijken van twee medicamenteuze behandelingen bij een miskraam |
|
|
| Ongoing | 4 | 60 | Europe | Tablet, Mifegyne | Radboudumc, Radboudumc, Exelgyn, Canisius-Wilhelmina Ziekenhuis | Women aged above 18 years with early pregnancy failure, 6-14 weeks postmenstrual., Women with a miscarriage., Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
ChiCTR-IPR-16007815: Evaluation of Therapeutic Effect and Safety of RU-486 in the Treatment of Adenomyosis with pain |
|
|
| Recruiting | 4 | 150 | | 2.5mg RU-486 po qd *12 months ;5mg RU-486 po qd*12 months ;25mg RU-486 po qw*11 months | Women's Hospital, School of Medicine, Zhejiang University; Women's Hospital, School of Medicine, Zhejiang University, self-financing | endometriosis and adenomyosis | | | | |
ChiCTR1800015514: Different low doses of mifepristone in the treatment of adenomyosis with dysmenorrhea: a non-randomized controlled study |
|
|
| Recruiting | 4 | 63 | | 2.5mg qd ;5mg qd ;25mg qw | Women's Hospital, School of Medicine, Zhejiang University; Women's Hospital, School of Medicine, Zhejiang University, self-financing | endometriosis and adenomyosis | | | | |
ChiCTR1900021247: A randomized, positive drug controlled, multi-center trial for Gongliuning in the treatment of uterine fibroids |
|
|
| Not yet recruiting | 4 | 520 | | Gongliuning tablets plus Mlfepristone ;Mifepristone ;Gonglouning tablets | Beijing Obstetrics and Gynecology Hospital, Capital Medical University; Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Gansu Taikang Pharmaceutical Co., Ltd. | Uterine leiomyoma | | | | |
NCT04458558: Improving Access to Abortion in the Republic of Georgia |
|
|
| Recruiting | 4 | 120 | RoW | Mifepristone | Center for Information and Counseling on Reproductive Health - Tanadgoma, Gynuity Health Projects, Healthy Life, Grand Challenges Canada | Abortion Early, Pregnancy Related | 04/21 | 04/21 | | |
ChiCTR2000031656: Comparison of the therapeutic effect of Dinogest and mifepristone on adenomyosis |
|
|
| Not yet recruiting | 4 | 200 | | dinogest ;mifepristone ;GnRHa, dinogest ;GnRHa, mifepristone | Women's Hospital, School of Medicine, Zhejiang University; Women's Hospital, School of Medicine, Zhejiang University, none | Adenomyosis | | | | |
ChiCTR2000031698: Comparison of GnRHa and mifepristone in the treatment of adenomyosis: a randomized controlled trial. |
|
|
| Recruiting | 4 | 60 | | GnRHa ;Mifepristone | Women's Hospital, School of Medicine, Zhejiang University; Level of the institution：, none | aednomyosis | | | | |
ChiCTR2000031689: Comparison of GnRHa and mifepristone in the treatment of symptomatic endometriosis |
|
|
| Recruiting | 4 | 60 | | GnRHa ;Mifepristone | Department of Gynecology and Obstetrics Hospital Affiliated to Zhejiang University Medical College; Level of the institution：, None | Endometriosis | | | | |
ChiCTR2000041480: Randomized controlled trial comparing letrozole and mifepristone pretreatment in medical management of first trimester missed miscarriage |
|
|
| Recruiting | 4 | 294 | | mifepristone 200mg orally; letrozole 10mg once a day for 3 consecutive days | The University of Hong Kong - Shenzhen Hospital; The University of Hong Kong - Shenzhen Hospital, Department own funds | missed miscarriage | | | | |
| Completed | 4 | 536 | US | Mifepristone | Daniel Grossman, MD | Abortion Early, Pregnancy Related | 07/23 | 07/23 | | |
NCT05119439: Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks |
|
|
| Terminated | 4 | 23 | US | Mifepristone + 2 doses of misoprostol 800 mcg | Gynuity Health Projects, Society of Family Planning | Medical Abortion | 06/23 | 06/23 | | |
NCT05124314: Comparison of Two Different Drug Regimens for Medical Treatment of Early Pregnancy Loss |
|
|
| Recruiting | 4 | 220 | RoW | Mifepristone, Oral, 200 Mg, Mifegyne, Misoprostol Pill, Mispregnol | Clinical Hospital Merkur, University of Zagreb School of Medicine | Abortion, Missed | 10/23 | 10/23 | | |
MIST, NCT05322252: Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial |
|
|
| Recruiting | 4 | 30 | US | Mifepristone, Misoprostol | Washington University School of Medicine | Abortion, Second Trimester, PPROM, Rupture, Spontaneous, Fetal Demise, Fetal Death, Fetal Demise From Miscarriage, Fetal Death Before 22 Weeks With Retention of Dead Fetus, Pregnancy Loss, Pregnancy Complications | 12/24 | 12/25 | | |
NCT05341817: The Use of Letrozole or Mifepristone for Pretreatment of Medical Termination of Pregnancy |
|
|
| Recruiting | 4 | 144 | RoW | Letrozole, Mifepristone | KK Women's and Children's Hospital | Abortion in First Trimester | 08/24 | 11/24 | | |
